Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K T Tashima

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
JAMA|September 18, 1998
Cerebrospinal fluid levels of antiretroviral medications: abstract and commentaryK T Tashima
Annals of Internal Medicine|February 24, 2001
Diagnosis of acute HIV infection: it's time to get moving!T Flanigan, K T Tashima
Infectious Disease Clinics of North America|January 6, 2001
Antiretroviral therapy in the year 2000K T Tashima, T P Flanigan
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Sustained responses to dual nucleoside therapy in womenK T Tashima, T C Fiore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2001
Photo quiz. Disseminated Rhodocuccus equi infectionP Alonso, K T Tashima, I J Goldstein
The New England Journal of Medicine|January 9, 1997
Indinavir nephropathyK T Tashima, J D Horowitz, S Rosen
The Journal of Urology|November 20, 1997
Management of indinavir associated nephrolithiasisJ D Rich, B Ramratnam, M Chiang, et al.
AIDS (London, England)|July 23, 1999
Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees CM Ahmad, K T Tashima, A M Caliendo, et al.
Infection and Immunity|May 1, 1996
Relative importance of three iron-regulated outer membrane proteins for in vivo growth of Vibrio choleraeK T Tashima, P A Carroll, M B Rogers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2002
Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasmaK T Tashima, T P Flanigan, J Kurpewski, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
JAMA|September 18, 1998
Cerebrospinal fluid levels of antiretroviral medications: abstract and commentaryK T Tashima
Annals of Internal Medicine|February 24, 2001
Diagnosis of acute HIV infection: it's time to get moving!T Flanigan, K T Tashima
Infectious Disease Clinics of North America|January 6, 2001
Antiretroviral therapy in the year 2000K T Tashima, T P Flanigan
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Sustained responses to dual nucleoside therapy in womenK T Tashima, T C Fiore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2001
Photo quiz. Disseminated Rhodocuccus equi infectionP Alonso, K T Tashima, I J Goldstein
The New England Journal of Medicine|January 9, 1997
Indinavir nephropathyK T Tashima, J D Horowitz, S Rosen
The Journal of Urology|November 20, 1997
Management of indinavir associated nephrolithiasisJ D Rich, B Ramratnam, M Chiang, et al.
AIDS (London, England)|July 23, 1999
Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees CM Ahmad, K T Tashima, A M Caliendo, et al.
Infection and Immunity|May 1, 1996
Relative importance of three iron-regulated outer membrane proteins for in vivo growth of Vibrio choleraeK T Tashima, P A Carroll, M B Rogers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2002
Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasmaK T Tashima, T P Flanigan, J Kurpewski, et al.
Pageof 3